United States Bioresorbable Polymer Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The "Global Bioresorbable Polymer Market" is expected to reach at a High CAGR during the forecast period 2024-2031.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioresorbable-polymer-market?sb

Key Development:

United States: Recent Bioresorbable Polymer Developments

✅ In November 2025, Abbott Laboratories launched a next‐generation bioresorbable vascular scaffold designed for coronary artery disease, featuring improved polymer composition for enhanced flexibility and safety, advancing interventional cardiology options in the U.S. market.

✅ In October 2025, Boston Scientific introduced a new bioresorbable scaffold system with enhanced radial strength and drug‐elution technology for complex coronary lesions, targeting improved outcomes and reduced restenosis in cardiovascular procedures.

✅ In September 2025, Medtronic initiated a clinical trial for an advanced bioresorbable scaffold combining polymer with anti‐proliferative coating to enhance long‐term vessel patency and reduce thrombosis, engaging multiple U.S. cardiology centers.

✅ In August 2025, Terumo Medical Corporation expanded its bioresorbable vascular scaffold portfolio with flexible, thin‐strut scaffolds optimized for tortuous coronary anatomy and improved resorption rates, highlighting U.S. innovation in polymer‐based cardiovascular devices.

Japan: Recent Bioresorbable Polymer Developments

✅ In November 2025, Terumo Corporation launched a bioresorbable vascular scaffold for coronary interventions in Japanese hospitals, featuring controlled drug release and polymer design to minimize restenosis and support vessel remodeling.

✅ In October 2025, Nipro Corporation introduced a next‐generation bioresorbable vascular scaffold that combines advanced polymers with anti‐proliferative coatings to improve long‐term vessel performance, expanding innovative scaffold options in Japan.

✅ In September 2025, Terumo Cardiovascular Systems Japan began a clinical trial evaluating a new bioresorbable scaffold system with enhanced flexibility and drug‐elution capabilities to treat coronary artery disease, emphasizing evidence‐based polymer innovation.

✅ In August 2025, Kaneka Corporation expanded its cardiovascular portfolio with a bioresorbable scaffold optimized for minimal strut thickness and improved deliverability, addressing procedural safety and long‐term outcomes in Japan.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-polymer-market

Key Players:

=> Corbion N.V., Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM Biomedical, Inc, Ashland Global Holdings Inc., Zeus Industrial Products, Inc, Seqens Group, REVA Medical, LLC, Poly-Med Incorporated, Bezwada Biomedical, LLC, Nomisma Healthcare Pvt. Ltd., BMG Incorporated, among others.

Key Segments:

By Type

Polylactic Acid (PLA) dominates with 30% share, driven by high biocompatibility, biodegradability, and strong adoption in drug delivery and packaging applications. Polyglycolic Acid (PGA) accounts for 20%, supported by its use in surgical implants, tissue engineering, and medical devices. Poly(lactic-co-glycolic acid) (PLGA) holds 25%, fueled by rising demand in controlled drug delivery systems and regenerative medicine. Polycaprolactone (PCL) represents 15%, driven by its flexibility, slow degradation rate, and use in 3D printing filaments and scaffolds. Others account for 10%, including emerging biodegradable polymers with specialized medical and industrial applications.

By Form

Powder leads with 40% share, due to versatility in pharmaceutical formulations, tissue engineering, and 3D printing applications. Tablet accounts for 30%, supported by oral drug delivery systems and biodegradable medical implants. Others represent 30%, including films, fibers, granules, and composite formulations used in diverse industrial and medical applications.

By Application

Drug Delivery dominates with 35% share, driven by growing demand for targeted, controlled-release, and biocompatible delivery systems. Orthopedics accounts for 25%, supported by biodegradable implants, screws, and bone scaffolds. 3D-Printing Filaments hold 20%, fueled by adoption in tissue engineering, medical prototypes, and customized implants. Others represent 20%, including packaging, agriculture, and environmental applications of biodegradable polymers.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioresorbable-polymer-market?sb

By Region

North America - 34% Share
North America leads with 34%, driven by advanced healthcare infrastructure, strong R&D in biodegradable polymers, and adoption in pharmaceuticals and 3D printing in the U.S. and Canada.

Europe - 28% Share
Europe holds 28%, supported by stringent environmental regulations, growing medical device sector, and strong adoption of PLA, PLGA, and PGA in Germany, France, U.K., and Italy.

Asia Pacific - 25% Share
Asia Pacific accounts for 25%, fueled by rising pharmaceutical and healthcare manufacturing, increasing 3D printing adoption, and government initiatives promoting sustainable polymers in China, India, Japan, and Southeast Asia.

Latin America - 8% Share
Latin America holds 8%, driven by increasing healthcare infrastructure, pharmaceutical applications, and growing awareness of sustainable materials in Brazil and Mexico.

Middle East & Africa - 5% Share
Middle East & Africa represent 5%, supported by adoption in medical implants, niche industrial applications, and rising healthcare investments in GCC countries and South Africa.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.